SB 258719

CAS No. 195199-95-2

SB 258719 ( —— )

Catalog No. M26434 CAS No. 195199-95-2

SB 258719 is a selective antagonist of 5-HT7 receptor with pKi of 7.5.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 76 Get Quote
10MG 123 Get Quote
25MG 249 Get Quote
50MG 401 Get Quote
100MG 593 Get Quote
500MG 1242 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SB 258719
  • Note
    Research use only, not for human use.
  • Brief Description
    SB 258719 is a selective antagonist of 5-HT7 receptor with pKi of 7.5.
  • Description
    SB 258719 is a selective antagonist of 5-HT7 receptor with pKi of 7.5.(In Vitro):SB 258719 antagonised surmountably 5-CT-stimulated adenylyl cyclase activity. Schild analysis of the antagonism by SB 258719 gave a pA2?of 7.2±0.2 and slope not significantly different from 1, consistent with competitive antagonism.(In Vivo):SB 258719 (5-20 mg/kg, i.p.) reversed the hypothermic effect of 5-CT in mice. Increased Wnt/β-catenin activity was attenuated by SB 258719 in HCC cell lines and patient-derived primary tumour tissues in the presence of 5-HT. SB 258719 also reduced tumour growth in vivo.
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    195199-95-2
  • Formula Weight
    338.5
  • Molecular Formula
    C18H30N2O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@H](CCN1CCC(C)CC1)N(C)S(=O)(=O)c1cccc(C)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Shimada Y, et al. Identification of a novel dihydrodaidzein racemase essential for biosynthesis of equol from daidzein in Lactococcus sp. strain 20-92. Appl Environ Microbiol. 2012 Jul;78(14):4902-7.
molnova catalog
related products
  • Metadoxine

    It is neurotransmitter stimulants.

  • Olanzapine

    Olanzapine is an atypical antipsychotic, approved by the FDA in 1996.

  • Ro 60-0175

    Ro 60-0175 is a potent, selective 5-HT2C receptor agonist.